ecrin-mdr-crcClinical2021Advanced Metastatic Colorectal CancerColorectal NeoplasmsAdvanced Metastatic Colorectal CancerColorectal NeoplasmsInterventionalhttps://newmdr.ecrin.org/Study/2398610China11RaltitrexedIrinotecanFirst-line TreatmentCetuximabBevacizumabECRIN MDRRecruitingfalseSALIRI Based Regimen as First-line Treatment for Advanced Metastatic Colorectal CancerThe objective is to investigate the efficacy and safety of raltitrexed combined with Irinotecan (SALIRI) based regimen as first-line treatment for advanced metastatic colorectal cancer(mCRC).2021-11-152398610NCT05160896